Australia's most trusted
source of pharma news
Friday, 19 June 2026
Posted 19 June 2026 AM
Sandoz is actively working to avoid any market disruptions as Seqirus starts to discontinue its injectable antibiotic Benpen, with the company aiming to list its own product – and the most popular strength - on the PBS on 1 August.
Benzylpenicillin sodium, the active ingredient in BenPen, is widely used to treat infections caused by susceptible Gram-positive bacteria and to prevent infections following surgery and other medical procedures.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.